Outcomes of Acute Myocardial Infarction in Patients with Familial Hypercholesteremia

Ayman Elbadawi, Islam Y. Elgendy, Mohamed Omer, Mohamed Abdelazeem, Vijay Nambi, Chayakrit Krittanawong, Ravi S. Hira, Jacqueline Tamis-Holland, Christie Ballantyne, Hani Jneid

Research output: Contribution to journalArticlepeer-review


Background: There is a paucity of contemporary data regarding the outcomes of acute myocardial infarction among patients with familial hypercholesteremia. Methods: We queried the Nationwide Readmissions Database (2016-2018) for hospitalizations with acute myocardial infarction. Multivariable regression analysis was used to compare in-hospital outcomes and 30-day readmissions among patients with and without familial hypercholesteremia. Results: The analysis included 1,363,488 hospitalizations with acute myocardial infarction. The prevalence of familial hypercholesteremia was 0.07% among acute myocardial infarction admissions. Compared with those without familial hypercholesteremia, admissions with familial hypercholesteremia were younger and had less comorbidities but were more likely to have had prior infarct and revascularization. Admissions with familial hypercholesteremia were more likely to present with ST-elevation myocardial infarction and undergo revascularization. After multivariable adjustment, there was no difference in in-hospital case fatality among patients with hypercholesteremia compared with those without it (adjusted odds ratio [aOR] = 0.76; 95% confidence interval [CI] 0.41-1.39). Admissions with acute myocardial infarction and familial hypercholesteremia had higher adjusted rates of cardiac arrest and utilization of mechanical support. There were no group differences in overall 30-day readmission (aOR 0.75; 95% CI 0.51-1.10) or 30-day readmission for acute myocardial infarction. However, a nonsignificant trend toward higher readmission for percutaneous coronary intervention was observed among patients with familial hypercholesteremia (aOR 1.89; 95% CI 0.98-3.64). Conclusion: In this contemporary nationwide observational analysis, patients with familial hypercholesteremia represent a small proportion of the overall population with acute myocardial infarction and have a distinctive clinical profile but do not appear to have worse in-hospital case fatality compared with those without familial hypercholesteremia.

Original languageEnglish (US)
Pages (from-to)992-1001.e4
JournalAmerican Journal of Medicine
Issue number8
StatePublished - Aug 2021
Externally publishedYes


  • Acute myocardial infarction
  • Dyslipidemia
  • Familial hypercholesteremia
  • Premature coronary artery disease
  • ST-elevation myocardial infarction

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Outcomes of Acute Myocardial Infarction in Patients with Familial Hypercholesteremia'. Together they form a unique fingerprint.

Cite this